What Is Marfan Syndrome & What Causes It?
Marfan syndrome is one of a family of serious genetic connective tissue disorders. Conditions that can mimic Marfan syndrome and have similar complications include Loeys-Dietz syndrome and vascular Ehlers-Danlos syndrome. Therefore, accurate diagnosis is important to ensure appropriate treatment and risk management.
Marfan syndrome is caused by an abnormality of the gene that tells your body to produce a protein required for your connective tissue’s elasticity and strength (FBN1; fibrillin-1). Your connective tissue is what keeps your organs and other body structures in place. As a result, Marfan syndrome can affect many parts of your body. However, it most commonly causes problems with the heart, eyes, blood vessels and skeleton. The damage and effects can vary from mild to severe, depending on the individual. Most people with Marfan syndrome, including those with ‘mild’ Marfan syndrome, will develop some form of heart problem.
Loeys-Dietz syndrome (LDS) and vascular Ehlers-Danlos syndrome (vEDS) are much rarer genetic connective tissue disorders, and are caused by abnormalities of similarly important genes (for example, TGFBR1 and TGFBR2 for LDS and COL3A1 for vEDS). However, as they present similarly to Marfan syndrome, genetic testing is the only way to properly diagnose which condition a person has.
How Common Is Marfan Syndrome & How Is It Inherited?
Marfan syndrome (and LDS and vEDS) are autosomal dominant disorders, meaning it can be inherited from a parent, and affect men and women equally.
If a person with Marfan syndrome has a child, they have a 50% chance of passing the condition on.
But the condition can also spontaneously occur through a new genetic mutation (also called genetic variant). This is the case for approximately 25% of those with Marfan syndrome.
Overall, for every 10,000 people, Marfan syndrome is predicted to affect 2–3 individuals. While Marfan syndrome cannot be cured, massive improvements in treatments and management of the condition means modern-day patients far exceed the average lifespan of the disorder from even only a few decades ago. Where people with the disorder were once expected to only reach their mid-40s, many now live well into their 70s.